Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) EBT (2016 - 2025)

Historic EBT for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's EBT rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 707.61%. This contributed to the annual value of -$39.3 million for FY2024, which is 632.44% up from last year.
  • According to the latest figures from Q3 2025, Jaguar Health's EBT is -$9.6 million, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Jaguar Health's EBT's 5-year high stood at -$7.9 million during Q3 2023, with a 5-year trough of -$18.2 million in Q1 2022.
  • Over the past 5 years, Jaguar Health's median EBT value was -$10.6 million (recorded in 2025), while the average stood at -$11.2 million.
  • In the last 5 years, Jaguar Health's EBT plummeted by 6327.97% in 2021 and then soared by 4250.59% in 2022.
  • Jaguar Health's EBT (Quarter) stood at -$14.3 million in 2021, then soared by 42.51% to -$8.2 million in 2022, then fell by 13.08% to -$9.3 million in 2023, then decreased by 9.94% to -$10.2 million in 2024, then grew by 5.73% to -$9.6 million in 2025.
  • Its EBT was -$9.6 million in Q3 2025, compared to -$10.6 million in Q2 2025 and -$10.6 million in Q1 2025.